New diabetes clinical trial: A Study of Tirzepatide (LY3298176) Versus Placebo in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine With or Without Metformin

Published on: July 31, 2019 at 09:30PM
Condition:   Type 2 Diabetes
Interventions:   Drug: Tirzepatide;   Drug: Placebo
Sponsor:   Eli Lilly and Company
Not yet recruiting
https://ift.tt/32YnV8F